TELYF (TelyRx Holdings) ROCE %: -71.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TELYF TelyRx Holdings Inc TELYF
12 GF Score
Price $1.88
! 2 Warning Signs
View Full Analysis

What is TelyRx Holdings ROCE %?

TelyRx Holdings TELYF +1.62% 12 ROCE % is -71.00% as of Jun. 2026. GuruFocus rates TELYF with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. TelyRx Holdings's annualized ROCE % for the quarter that ended in Jun. 2026 was -71.00%.

TelyRx Holdings  (OTCPK:TELYF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

TelyRx Holdings ROCE % Related Terms

TelyRx Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for TelyRx Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TelyRx Holdings ROCE % Chart

TelyRx Holdings Annual Data
Trend Dec23 Dec24 Dec25
ROCE %
-15.12 -68.81 -2,109.33

TelyRx Holdings Quarterly Data
Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only 0.00 -83.99 0.00 -172.64 -71.00
TELYF
12GF Score
TelyRx Holdings Inc TELYF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TelyRx Holdings ROCE % Calculation

TelyRx Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-4.746/( ( (7.948 - 1.553) + (9.876 - 15.821) )/ 2 )
=-4.746/( (6.395+-5.945)/ 2 )
=-4.746/0.225
=-2,109.33 %

TelyRx Holdings's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=-17.76/( ( (34.197 - 7.668) + (30.866 - 7.37) )/ 2 )
=-17.76/( ( 26.529 + 23.496 )/ 2 )
=-17.76/25.0125
=-71.00 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -71.00% mean?
TelyRx Holdings (TELYF) has a ROCE % of -71.00% as of Jun. 2026.
Is TelyRx Holdings' ROCE % too high?
TelyRx Holdings' current ROCE % is -71.00%. Overall, TelyRx Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TelyRx Holdings' ROCE % compare to ?
TelyRx Holdings' ROCE % of -71.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.77, based on 647 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TelyRx Holdings's current ROCE % is -71.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TelyRx Holdings stock overvalued right now?
TelyRx Holdings (TELYF) has a current ROCE % of -71.00%. The current ROCE % is -71.00%. TelyRx Holdings' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For TelyRx Holdings (TELYF), the current ROCE % is -71.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TelyRx Holdings Business Description

Comparable Companies
Other Exchanges TELY:Canada
Address 24761 US Highway 19 North, Clearwater, FL, USA, 33763
TelyRx Holdings Inc is a vertically integrated technology enabled healthcare and pharmacy services provider, operating a digital pharmacy platform that connects patients with independent, state-licensed providers. The TelyRx platform provides the Providers with access to a clinically focused electronic medical records system and the ability for them to electronically prescribe. TelyRx enables patient access to a risk-curated formulary of over 450 noncontrolled, and non-compounded prescription medications selected by the Providers to address a broad cross-section of everyday chronic and acute ailments.
12GF Score

Get the complete analysis for TELYF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.88
Price